Biliary Complications and Management After Liver Transplantation.

IF 0.8
Tufan Egeli, Ibrahim Kemal Astarcioglu, Tarkan Unek, Mucahit Ozbilgin, Cihan Agalar, Aytac Gulcu, Mesut Akarsu, Nilay Danis, Aylin Bacakoglu, Berkay Sakaoglu, Emre Karadeniz, Huseyin Astarcioglu, Sedat Karademir
{"title":"Biliary Complications and Management After Liver Transplantation.","authors":"Tufan Egeli, Ibrahim Kemal Astarcioglu, Tarkan Unek, Mucahit Ozbilgin, Cihan Agalar, Aytac Gulcu, Mesut Akarsu, Nilay Danis, Aylin Bacakoglu, Berkay Sakaoglu, Emre Karadeniz, Huseyin Astarcioglu, Sedat Karademir","doi":"10.1016/j.transproceed.2025.07.002","DOIUrl":null,"url":null,"abstract":"<p><strong>Aim: </strong>To investigate the incidence, causes, and treatment methods of biliary complications (BC) following liver transplantation (LT).</p><p><strong>Patients and methods: </strong>Patients who underwent LT between February 1997 and 2024 were identified. Cases with BC were determined. Patients aged 18 years and older were classified as adults. Patients who experienced mortality within the first postoperative week or had spontaneous regression of bile drainage were excluded. The study aimed to evaluate the incidence and types of BC, complications associations between recipient/donor characteristics, graft type, steatosis, cold ischemia time (CIT), number of bile ducts, donor hepatectomy technique, and type of biliary reconstruction. Additionally, treatment methods, morbidity, and mortality rates were analyzed.</p><p><strong>Results: </strong>A total of 590 patients were included in the study. BC occurred in 49 patients (8.2%). In the multivariate analysis including all patients, living donor LT and prolonged CIT were identified as risk factors for the development of BC (P ≤ .001 and P ≤ .001, respectively). In the multivariate analysis conducted exclusively on cases who underwent LT due to cirrhosis, the factors associated with the development of BC were identified as living donor transplantation (P = .001), prolonged CIT (P ≤ .001), and viral etiology (P = .046). Complications were managed using endoscopic and interventional radiologic techniques. Mortality due to BC occurred in 19 (38.7%) of the cases.</p><p><strong>Conclusion: </strong>BC are still a significant challenge in LT. Identifying and avoiding causative factors and strict selection criteria may substantially reduce the incidence of BC. Effective treatment can be achieved through a multidisciplinary approach in most cases.</p>","PeriodicalId":94258,"journal":{"name":"Transplantation proceedings","volume":" ","pages":""},"PeriodicalIF":0.8000,"publicationDate":"2025-07-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Transplantation proceedings","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1016/j.transproceed.2025.07.002","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Aim: To investigate the incidence, causes, and treatment methods of biliary complications (BC) following liver transplantation (LT).

Patients and methods: Patients who underwent LT between February 1997 and 2024 were identified. Cases with BC were determined. Patients aged 18 years and older were classified as adults. Patients who experienced mortality within the first postoperative week or had spontaneous regression of bile drainage were excluded. The study aimed to evaluate the incidence and types of BC, complications associations between recipient/donor characteristics, graft type, steatosis, cold ischemia time (CIT), number of bile ducts, donor hepatectomy technique, and type of biliary reconstruction. Additionally, treatment methods, morbidity, and mortality rates were analyzed.

Results: A total of 590 patients were included in the study. BC occurred in 49 patients (8.2%). In the multivariate analysis including all patients, living donor LT and prolonged CIT were identified as risk factors for the development of BC (P ≤ .001 and P ≤ .001, respectively). In the multivariate analysis conducted exclusively on cases who underwent LT due to cirrhosis, the factors associated with the development of BC were identified as living donor transplantation (P = .001), prolonged CIT (P ≤ .001), and viral etiology (P = .046). Complications were managed using endoscopic and interventional radiologic techniques. Mortality due to BC occurred in 19 (38.7%) of the cases.

Conclusion: BC are still a significant challenge in LT. Identifying and avoiding causative factors and strict selection criteria may substantially reduce the incidence of BC. Effective treatment can be achieved through a multidisciplinary approach in most cases.

肝移植术后胆道并发症及处理。
目的:探讨肝移植术后胆道并发症(BC)的发生率、原因及治疗方法。患者和方法:1997年2月至2024年间接受肝移植的患者。确定了BC病例。18岁及以上的患者被归类为成人。排除术后第一周内死亡或胆汁引流自发消退的患者。本研究旨在评估BC的发生率和类型、受体/供体特征、移植物类型、脂肪变性、冷缺血时间(CIT)、胆管数量、供肝切除技术和胆道重建类型之间的并发症关系。此外,还分析了治疗方法、发病率和死亡率。结果:共纳入590例患者。49例(8.2%)发生BC。在包括所有患者的多因素分析中,活体供体LT和延长CIT被确定为BC发展的危险因素(P≤0.001和P≤0.001)。在对肝硬化肝移植患者进行的多因素分析中,与BC发展相关的因素被确定为活体供体移植(P = 0.001)、CIT延长(P≤0.001)和病毒病因(P = 0.046)。并发症的处理采用内镜和介入放射技术。19例(38.7%)病例死于BC。结论:BC仍然是lt的一个重大挑战,识别和避免致病因素,严格的选择标准可以大大降低BC的发病率。在大多数情况下,通过多学科方法可以实现有效的治疗。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信